Choreo LLC Makes New $419,000 Investment in Option Care Health, Inc. $OPCH

Posted by Stanley Muller on Nov 7th, 2026

Choreo LLC purchased a new position in shares of Option Care Health, Inc. (NASDAQ:OPCH – Free Report) in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 18,627 shares of the company’s stock, valued at approximately $419,000.

Several other hedge funds have also recently made changes to their positions in OPCH. Reyes Financial Architecture Inc. bought a new stake in shares of Option Care Health during the 3rd quarter valued at $28,000. Harbor Investment Advisory LLC bought a new stake in shares of Option Care Health during the second quarter valued at approximately $48,000. Nykredit A S acquired a new stake in Option Care Health during the second quarter worth $56,000. Public Employees Retirement System of Ohio acquired a new stake in Option Care Health during the 2nd quarter worth approximately $66,000. Finally, Nisa Investment Advisors LLC increased its stake in shares of Option Care Health by 268.9% in the 3rd quarter. Nisa Investment Advisors LLC now owns 2,955 shares of the company’s stock valued at $66,000 after purchasing an additional 2,154 shares during the last quarter. 98.05% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on OPCH. Wall Street Zen raised shares of Option Care Health from a “hold” rating to a “buy” rating in a research report on Saturday, August 1st. JPMorgan Chase & Co. downgraded shares of Option Care Health from an “overweight” rating to a “neutral” rating and set a $33.00 price objective for the company. in a research report on Wednesday, October 7th. Stephens cut Option Care Health from an “overweight” rating to an “equal weight” rating and cut their price objective for the stock from $30.00 to $24.00 in a research report on Friday, July 17th. Barrington Research lowered shares of Option Care Health from an “outperform” rating to a “hold” rating in a research note on Wednesday, October 7th. Finally, Citizens Jmp downgraded Option Care Health from a “market outperform” rating to a “hold” rating in a report on Wednesday, October 7th. Two research analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the stock. According to data from MarketBeat, Option Care Health currently has a consensus rating of “Hold” and a consensus target price of $29.48.

Read Our Latest Research Report on Option Care Health

Option Care Health Trading Up 0.5%

Option Care Health stock opened at $31.65 on Friday. Option Care Health, Inc. has a 52 week low of $18.01 and a 52 week high of $36.80. The stock has a 50-day moving average price of $27.30 and a 200 day moving average price of $26.37. The company has a current ratio of 1.47, a quick ratio of 0.98 and a debt-to-equity ratio of 0.91. The stock has a market cap of $4.74 billion, a PE ratio of 20.06, a P/E/G ratio of 1.93 and a beta of 0.47.

Option Care Health (NASDAQ:OPCH – Get Free Report) last released its quarterly earnings results on Wednesday, November 4th. The company reported $0.49 EPS for the quarter, meeting analysts’ consensus estimates of $0.49. Option Care Health had a net margin of 3.68% and a return on equity of 18.74%. The company had revenue of $1.49 billion for the quarter, compared to analyst estimates of $1.48 billion. During the same quarter last year, the firm posted $0.45 earnings per share. The company’s quarterly revenue was up 4.1% compared to the same quarter last year. Equities research analysts predict that Option Care Health, Inc. will post 1.70 earnings per share for the current fiscal year.

About Option Care Health

(Free Report)

Option Care Health, Inc is an independent provider of home and alternate-site infusion services in the United States. The company coordinates and delivers infusion therapy outside traditional hospital settings, including patients’ homes, ambulatory infusion suites and other outpatient locations.

Its services include administration of anti-infective therapies, immune globulin, nutrition support, inotropic therapies and medications used in the treatment of chronic and complex conditions.